1. Home
  2. ALT vs FMAO Comparison

ALT vs FMAO Comparison

Compare ALT & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • FMAO
  • Stock Information
  • Founded
  • ALT 1997
  • FMAO 1897
  • Country
  • ALT United States
  • FMAO United States
  • Employees
  • ALT N/A
  • FMAO N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • FMAO Savings Institutions
  • Sector
  • ALT Health Care
  • FMAO Finance
  • Exchange
  • ALT Nasdaq
  • FMAO Nasdaq
  • Market Cap
  • ALT 292.0M
  • FMAO 356.9M
  • IPO Year
  • ALT N/A
  • FMAO N/A
  • Fundamental
  • Price
  • ALT $3.83
  • FMAO $26.13
  • Analyst Decision
  • ALT Strong Buy
  • FMAO
  • Analyst Count
  • ALT 6
  • FMAO 0
  • Target Price
  • ALT $17.40
  • FMAO N/A
  • AVG Volume (30 Days)
  • ALT 3.0M
  • FMAO 21.8K
  • Earning Date
  • ALT 08-12-2025
  • FMAO 10-29-2025
  • Dividend Yield
  • ALT N/A
  • FMAO 3.34%
  • EPS Growth
  • ALT N/A
  • FMAO 38.39
  • EPS
  • ALT N/A
  • FMAO 2.16
  • Revenue
  • ALT $20,000.00
  • FMAO $108,632,000.00
  • Revenue This Year
  • ALT N/A
  • FMAO $1.60
  • Revenue Next Year
  • ALT $761,880.20
  • FMAO $13.77
  • P/E Ratio
  • ALT N/A
  • FMAO $12.26
  • Revenue Growth
  • ALT N/A
  • FMAO 13.86
  • 52 Week Low
  • ALT $2.90
  • FMAO $20.88
  • 52 Week High
  • ALT $11.16
  • FMAO $34.15
  • Technical
  • Relative Strength Index (RSI)
  • ALT 51.79
  • FMAO 58.09
  • Support Level
  • ALT $3.35
  • FMAO $24.60
  • Resistance Level
  • ALT $3.66
  • FMAO $27.01
  • Average True Range (ATR)
  • ALT 0.19
  • FMAO 0.81
  • MACD
  • ALT 0.07
  • FMAO 0.23
  • Stochastic Oscillator
  • ALT 86.18
  • FMAO 89.44

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About FMAO Farmers & Merchants Bancorp Inc.

Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.

Share on Social Networks: